This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Inamed Says Allergan Bid Is Superior

Cosmetic-surgery supplier Inamed (IMDC) conceded Wednesday that a $3.2 billion buyout offer proffered by Allergan (AGN - Get Report) is probably superior to an existing bid from Medicis (MRX).

Inamed said directors meeting Wednesday "determined that the Allergan proposal is reasonably likely to result in a 'company superior proposal'" as defined in its March 20 merger agreement with Medicis. The board directed management to evaluate the offer, which comes out to $84 a share in stock and cash.

Medicis' offer was worth $75 a share, or $2.8 billion, when it was made. Medicis, which makes treatments for skin diseases and other products, offered $30 cash plus 1.4205 of its shares.

In touting the superiority of its bid Tuesday, Allergan noted that it's offering a higher component of cash than the Medicis, a more liquid stock, a higher premium and the possibility of quicker completion.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MRX $0.00 0.00%
IMDC $0.02 0.00%
AGN $278.58 0.00%
AAPL $110.78 0.00%
FB $94.01 0.00%


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs